In China, it is currently difficult to find a quality in-country solution to your central imaging needs. At the moment, Sponsors are being forced to look abroad for solutions which increases costs, causes delays, and invites unnecessary complications to the management of a process that could otherwise be avoided. That is why CSC has begun developing a solution in-house. Our goal is to provide our clients with a seamless, end-to-end service scope, and by introducing Central Imaging to our business model, we are getting one step closer to attaining that goal.
Our system is currently under beta-testing. We are planning to launch in 2020.
If you would like to receive updates on our progress or learn more about our future service provisions, feel free to get in touch.
More About the Clinical Service Center CRO
OUR LEADERSHIP TEAM
Our senior managers and executives were trained in the West, have worked for big Western pharmaceutical companies, and are committed to bringing the best clinical practices to China.
For more than a decade, Clinical Service Center-“CSC” (formerly Beijing Clinical Service Center – “BCSC”) has been conducting top-quality clinical trial services in China for pharmaceutical, biotech, and medical device companies the world over.
FULL SERVICE PLUS
At CSC we define our business scope as “full-service plus” because we go above and beyond the requirements of a traditional full-service CRO to provide you with the end-to-end services you require to get your product in to the China market.